Abbott India
Ticker > Company >

Abbott India share price

Abbott India Ltd.

NSE: ABBOTINDIA BSE: 500488 SECTOR: Pharmaceuticals & Drugs  165k   1k   134

28755.85
+242.55 (0.85%)
NSE: Today, 02:54 PM

Price Summary

Today's High

₹ 28855.85

Today's Low

₹ 28201.25

52 Week High

₹ 30521

52 Week Low

₹ 22500

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 61104.17 Cr.

Enterprise Value

₹ 58969.68 Cr.

No. of Shares

2.12 Cr.

P/E

47.56

P/B

17.35

Face Value

₹ 10

Div. Yield

1.44 %

Book Value (TTM)

₹  1657.05

CASH

₹ 2134.49 Cr.

DEBT

₹ 0 Cr.

Promoter Holding

74.99 %

EPS (TTM)

₹  604.57

Sales Growth

9.35%

ROE

35.31 %

ROCE

47.34%

Profit Growth

26.52 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Abbott India Ltd.

BRUFEN Digene DUPHALAC Zolfresh Cremaffin Solspre Cremalax Ganaton LIBRAX THYROCAB Eptoin OBIMET SOLFE Wymox

Index Presence

The company is present in 29 Indices.

NYMIDSML400MQ100

Nifty MidSmallcap400 Momentum Quality 100 Index
51616.2
  -36.9000000000015 (-0.0714381131045383%)

NFTMIDSMLHEALTH

Nifty MidSmall Healthcare
42963.3
  15.5500000000029 (0.036206786152948%)

NIFTYMNC

Nifty MNC
27927.65
  -12.5999999999985 (-0.0450962321382198%)

NMID150Q50

NIFTY Midcap150 Quality 50
24194.25
  -67.2999999999993 (-0.277393653744296%)

NIFTYPHARMA

Nifty Pharma
22649.65
  90.75 (0.402280253026532%)

NIFTY500

Nifty 500
22407.7
  5 (0.0223187383663559%)

NIFTYMIDCAP150

Nifty Midcap 150
21037.2
  -43.5 (-0.206349884017132%)

NFTMIDSMLINCONS

Nifty MidSmall India Consumption
20301.7
  -28.75 (-0.141413495520271%)

NIFTYMIDSMALL400

Nifty MidSmallcap 400
19869.15
  -39.75 (-0.199659448789236%)

NIF500LGMIDSML

Nifty500 LargeMidSmall Equal-Cap Weighted Index
17550.45
  -16.7999999999993 (-0.0956324979720757%)

NY500MUL50:25:25

Nifty500 Multicap 50:25:25
15782
  -7 (-0.0443346633732356%)

NIFTYLGEMID250

NIFTY LargeMidcap 250
15708.1
  -8 (-0.0509032139016652%)

NY500MUL50:30:20

Nifty500 Multicap India Manufacturing 50:30:20
14645.45
  15.0500000000011 (0.102868000874889%)

NIFTYHEALTH

Nifty Healthcare Index
14541.65
  72.0499999999993 (0.497940509758377%)

NFT500EQUAL

Nifty 500 Equal Weight
14143.35
  -25.3999999999996 (-0.179267754741952%)

NIFTYTOTALMCAP

NIFTY Total Market
12650.1
  -0.449999999998909 (-0.00355715759392528%)

MIDCAP

Bse MidCap
46310.76
  -3.25999999999476 (-0.00703890528179763%)

BSE HC

Bse Healthcare
44292.57
  200.529999999999 (0.454798643927568%)

BSE500

Bse 500
35250.68
  28.0299999999988 (0.0795794751388579%)

MID150

Bse 150 MidCap Index
15889.62
  -1.53999999999905 (-0.00969092250030501%)

200EQW

BSE 200 Equal Weight
12647.94
  16.7300000000014 (0.132449701968396%)

MSL400

Bse 400 MidSmallCap Index
12111.12
  -3.46999999999935 (-0.0286431484680771%)

BSE200

Bse 200
10968.01
  11.6800000000003 (0.106605040191377%)

LMI250

Bse 250 LargeMidCap Index
10409.71
  9.96999999999935 (0.0958677813099218%)

SPBSQIP

Bse Quality Index
1793.45
  3.06999999999994 (0.171471978015836%)

SPBSLVIP

Bse Low Volatility Index
1755.25
  -3.8599999999999 (-0.219429143146244%)

ALLCAP

Bse Allcap
10471.31
  71.0699999999997 (0.683349615008888%)

S&P LARGEMIDCAP

Bse LargeMidCap
10285.25
  -7.07999999999993 (-0.0687890885737286%)

S&P MIDSMLCAP

Bse MidSmallCap
13523.19
  31.9400000000005 (0.236746039099422%)

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year9.35%
3 Year10.71%
5 Year9.72%

Profit Growth

1 Year26.52%
3 Year20.26%
5 Year21.68%

ROE%

1 Year35.31%
3 Year32.44%
5 Year30.46%

ROCE %

1 Year47.34%
3 Year43.6%
5 Year40.97%

Debt/Equity

0

Price to Cash Flow

50.38

Interest Cover Ratio

130.9398

CFO/PAT (5 Yr. Avg.)

1.04105411119905

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 74.99 0.00
Jun 2024 74.99 0.00
Mar 2024 74.99 0.00
Dec 2023 74.99 0.00
Sep 2023 74.99 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 20.2577651567425% for the Past 3 years.
  • Company has been maintaining healthy ROE of 32.4404005809797% over the past 3 years.
  • Company has been maintaining healthy ROCE of 43.6017165641513% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 130.9398.
  • The Company has been maintaining an effective average operating margins of 21.3093032132571% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -49.798 days.
  • Company has a healthy liquidity position with current ratio of 2.4174.
  • The company has a good cash flow management; CFO/PAT stands at 1.04105411119905.
  • The company has a high promoter holding of 74.99%.

 Limitations

  • The company has shown a poor revenue growth of 10.7128700036431% for the Past 3 years.
  • The company is trading at a high PE of 47.56.
  • The company is trading at a high EV/EBITDA of 32.8129.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 1494.14 1437.14 1438.63 1557.61 1632.67
Total Expenditure 1113.26 1049.45 1109.1 1166.6 1193.71
Operating Profit 380.88 387.69 329.53 391.01 438.96
Other Income 55.51 55.61 81.15 67.33 60.48
Interest 3.13 3.17 2.81 2.75 2.5
Depreciation 17.84 17.97 18.19 18.37 17.51
Exceptional Items 0 0 0 0 0
Profit Before Tax 415.42 422.16 389.68 437.22 479.43
Tax 102.48 111.18 102.62 109.21 120.82
Profit After Tax 312.94 310.98 287.06 328.01 358.61
Adjusted EPS (Rs) 147.27 146.34 135.09 154.36 168.76

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 4093.14 4310.02 4913.32 5348.73 5848.91
Total Expenditure 3336.96 3391.13 3831.74 4143.24 4395.86
Operating Profit 756.18 918.89 1081.58 1205.49 1453.05
Other Income 114.66 83.47 83.35 154.29 248.32
Interest 8.53 18.28 19.1 15.99 12.45
Depreciation 59.61 58.13 66.1 69.97 71.17
Exceptional Items 0 0 0 0 0
Profit Before Tax 802.7 925.95 1079.73 1273.82 1617.75
Tax 209.77 235.26 281.03 324.41 416.53
Net Profit 592.93 690.69 798.7 949.41 1201.22
Adjusted EPS (Rs.) 279.03 325.03 375.86 446.78 565.28

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 21.25 21.25 21.25 21.25 21.25
Total Reserves 2410.45 2580.91 2798.54 3167.29 3677.64
Borrowings 0 0 0 0 0
Other N/C liabilities 209.6 189.62 184.18 144.02 136.03
Current liabilities 891.11 1030.86 1203.19 1206.02 1342.72
Total Liabilities 3532.41 3822.64 4207.16 4538.58 5177.64
Assets
Net Block 269.83 250.78 271 236.91 224.94
Capital WIP 1.64 0.66 0.66 3.66 10.11
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 50.91 78.8 79.35 97.88 80.18
Other N/C Assets 5.38 4.99 3.11 1175.02 1616.57
Current Assets 3204.65 3487.41 3853.04 3025.11 3245.84
Total Assets 3532.41 3822.64 4207.16 4538.58 5177.64
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 802.7 925.95 1079.73 1273.82 1617.75
Adjustment -17.22 24.99 23.3 -62.7 -129.85
Changes in Assets & Liabilities 69.82 11.26 133.62 23.13 129.38
Tax Paid -229.17 -235.46 -288.99 -340.86 -404.47
Operating Cash Flow 626.13 726.74 947.66 893.39 1212.81
Investing Cash Flow -401.21 -71.82 -395.84 -147.71 -416.03
Financing Cash Flow -216.79 -581.79 -637.38 -638.72 -744.71
Net Cash Flow 8.13 73.13 -85.56 106.96 52.07

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 74.99 74.99 74.99 74.99 74.99
abbott capital india limi... 50.44 50.44 50.44 50.44 50.44
abbott healthcare product... 17.62 17.62 17.62 17.62 17.62
british colloids limited 6.92 6.92 6.92 - 6.92
british colloids ltd - - - 6.92 -
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 25.01 25.01 25.01 25.01 25.01
canara robeco mutual fund... - - - - 1.26
investor education and pr... - 0.49 0.49 - 0.54
sbi arbitrage opportuniti... 1.57 1.56 - 2.20 2.58
canara robeco mutual fund... 1.29 1.26 1.25 1.43 -
investor education and pr... 0.50 - - 0.49 -
sbi nifty midcap 150 inde... - - 1.88 - -

Annual Reports

Ratings & Research Reports

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Abbott India informs about closure of trading window 23 Dec, 11:50 AM Abbott India launches Pneumococcal Conjugate Vaccine ‘PneumoShield 14’ 28 Nov, 4:30 PM Abbott India informs about issuance of duplicate share certificate 8 Nov, 5:13 PM Abbott India - Quaterly Results 7 Nov, 1:29 PM Abbott India - Quaterly Results 7 Nov, 1:29 PM Abbott India - Quaterly Results 7 Nov, 1:29 PM Abbott India informs about loss of share certificate 5 Nov, 3:17 PM Abbott India informs about change in management 18 Oct, 4:13 PM Abbott India informs about compliances-certificate 11 Oct, 4:24 PM Abbott India informs about trading window closure 26 Sep, 4:45 PM Abbott India signs patent license agreement with Takeda Pharmaceuticals 20 Sep, 9:21 AM Abbott India informs about updates 31 Aug, 11:35 AM Abbott India - Quaterly Results 7 Aug, 5:53 PM Abbott India - Quaterly Results 7 Aug, 5:53 PM Abbott India - Quaterly Results 7 Aug, 5:53 PM Abbott India informs about board meeting 30 Jul, 2:55 PM Abbott India informs about change in management 23 Jul, 1:05 PM Abbott India informs about resignation of director 11 Jun, 12:04 PM Abbott India - Quaterly Results 9 May, 6:36 PM Abbott India - Quaterly Results 9 May, 6:36 PM Abbott India informs about appointment of senior management personnel 12 Apr, 10:59 AM Abbott India informs about newspaper advertisement 27 Mar, 2:50 PM Abbott India informs about resignation of managing director 19 Mar, 12:16 PM Abbott India informs about change in senior management personnel 15 Mar, 3:31 PM Abbott India informs about change in directorate 13 Mar, 1:00 PM Abbott India - Quaterly Results 1 Feb, 5:46 PM Abbott India - Quaterly Results 1 Feb, 5:46 PM Abbott India - Quaterly Results 1 Feb, 5:46 PM Abbott India informs about board meeting 18 Jan, 3:29 PM Abbott India - Quaterly Results 9 Nov, 1:39 PM Abbott India - Quaterly Results 9 Nov, 1:39 PM Abbott India - Quaterly Results 9 Nov, 1:39 PM Abbott India informs about disclosure 11 Oct, 5:24 PM Abbott India informs about details of loss of certificate 16 Aug, 4:22 PM Abbott India - Quaterly Results 9 Aug, 6:49 PM Abbott India - Quaterly Results 9 Aug, 6:49 PM Abbott India - Quaterly Results 19 May, 4:03 PM Abbott India - Quaterly Results 19 May, 4:03 PM Abbott India - Quaterly Results 19 May, 4:03 PM Abbott India informs about issuance of duplicate share certificate 19 May, 11:10 AM Abbott India informs about non-applicability of large corporate entity 17 Apr, 12:03 PM Abbott India informs about details of loss of certificate 1 Mar, 5:19 PM Abbott India - Quaterly Results 10 Feb, 2:01 PM Abbott India - Quaterly Results 10 Feb, 2:01 PM Abbott India - Quaterly Results 10 Feb, 2:01 PM Abbott India informs about disclosure of related party transactions 25 Nov, 5:18 PM Abbott India informs about issuance of duplicate share certificate 16 Nov, 5:12 PM Abbott India informs about press release 15 Nov, 12:15 PM Abbott India - Quaterly Results 14 Nov, 1:17 PM Abbott India - Quaterly Results 14 Nov, 1:17 PM

Abbott India Stock Price Analysis and Quick Research Report. Is Abbott India an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Abbott India and its performance over the period of time. Abbott India stock price today is Rs 28755.85.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Abbott India cash from the operating activity was Rs 1212.81 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Abbott India has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Abbott India , the EPS growth was 26.5228 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Abbott India has OPM of 24.8430904219761 % which is a good sign for profitability.
     
  • ROE: Abbott India have a healthy ROE of 35.3053 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Abbott India is Rs 28755.85. One can use valuation calculators of ticker to know if Abbott India share price is undervalued or overvalued.
Last Updated on:
Brief about Abbott India

Abbott India Ltd. Financials: Check Share Price, Balance Sheet, Annual Report and Quarterly Results for Company Analysis

Abbott India Ltd. is a leading pharmaceutical company in India, providing a range of healthcare products and services. In this article, we will provide a comprehensive analysis of Abbott India Ltd. stock from a long-term investor's perspective. We will cover various topics such as share price, balance sheet, annual report, dividend, quarterly result, stock price, price chart, news, concall, transcripts, investor presentations, promoters, and shareholders.

Abbott India Ltd. Share Price:

Abbott India Ltd.'s share price is an important indicator of investor sentiment towards the company. The share price is influenced by various factors such as the company's financial performance, global economic conditions, and market sentiment. Long-term investors can use our pre-built screening tools to analyze Abbott India Ltd.'s share price and identify any trends or patterns. The company's share price has shown a stable trend over the past few years, reflecting the company's strong fundamentals.

Abbott India Ltd. Balance Sheet:

Abbott India Ltd.'s balance sheet provides crucial information about its financial health. The company's assets include investments, receivables, and other assets, while liabilities include borrowings, payables, and other liabilities. Equity includes share capital, reserves, and surplus. Long-term investors can use our pre-built screening tools to analyze Abbott India Ltd.'s balance sheet and identify any red flags. The company's balance sheet has shown a stable trend over the past few years, reflecting the company's strong financial position.

Abbott India Ltd. Annual Report:

Abbott India Ltd. releases an annual report every year, which provides detailed information about the company's financial performance, strategic initiatives, and future plans. The annual report includes a letter from the Chairman, financial statements, and management discussion and analysis. Long-term investors can download Abbott India Ltd.'s annual report from our website and use it to make informed investment decisions. The annual report provides valuable insights into the company's operations and financial performance.

Abbott India Ltd. Dividend:

Abbott India Ltd. has a consistent dividend payout history. The company has been paying dividends regularly, reflecting the company's strong financial position. Long-term investors should consider this when evaluating Abbott India Ltd.'s stock. Our pre-built screening tools can be used to analyze the company's dividend history and identify any trends or patterns.

Abbott India Ltd. Quarterly Results:

Abbott India Ltd. releases its quarterly results every three months. The quarterly results provide information about the company's revenue, earnings, and expenses. Long-term investors can use our pre-built screening tools to analyze Abbott India Ltd.'s quarterly results and identify any trends or patterns. The quarterly results are an important indicator of the company's financial health and performance.

Abbott India Ltd. Stock Price:

The stock price of Abbott India Ltd. is affected by various factors such as the company's financial performance, global economic conditions, and market sentiment. Long-term investors can use our pre-built screening tools to track Abbott India Ltd.'s stock price and identify potential buying opportunities. The stock price of Abbott India Ltd. has shown a stable trend over the past few years, reflecting the company's strong fundamentals.

Abbott India Ltd. Price Chart:

A price chart provides a visual representation of a company's stock price over a period of time. Long-term investors can use our pre-built screening tools to analyze Abbott India Ltd.'s price chart and identify any trends or patterns. The price chart shows that the stock price of Abbott India Ltd. has shown a stable trend over the past few years, reflecting the company's strong fundamentals.

Abbott India Ltd. News:

Keeping up to date with the latest news about Abbott India Ltd. is important for investors. Our website provides the latest news about Abbott India Ltd. from various sources such as financial news websites and social media. Long-term investors can use this information to make informed investment decisions.

Abbott India Ltd. Concall:

Abbott India Ltd. holds conference calls with analysts and investors to discuss its financial performance and future plans. Long-term investors can listen to Abbott India Ltd.'s concall and use the information provided to make informed investment decisions. Our website provides information about upcoming concalls and links to listen to past concalls.

Abbott India Ltd. Transcripts:

Transcripts of Abbott India Ltd.'s concalls are available on our website. Long-term investors can download the transcripts and use them to analyze the company's financial performance and future plans. The transcripts provide valuable insights into the company's operations and financial performance.

Abbott India Ltd. Investor Presentations:

Abbott India Ltd. provides investor presentations on its website. These presentations provide information about the company's financial performance, strategic initiatives, and future plans. Long-term investors can download Abbott India Ltd.'s investor presentations from our website and use them to make informed investment decisions. The investor presentations provide valuable insights into the company's operations and financial performance.

Abbott India Ltd. Promoters:

Promoters are individuals or entities that have a significant stake in a company. Abbott India Ltd.'s promoters include Abbott Laboratories and Abbott Healthcare Pvt. Ltd. Long-term investors can use our pre-built screening tools to analyze Abbott India Ltd.'s promoter holdings and identify any potential conflicts of interest. The promoter holdings of Abbott India Ltd. are relatively stable, which is a positive sign for long-term investors.

Abbott India Ltd. Shareholders:

Abbott India Ltd. has a large number of shareholders, including institutional investors and individual investors. Long-term investors can use our pre-built screening tools to analyze Abbott India Ltd.'s shareholder base and identify any potential risks or opportunities. The shareholder base of Abbott India Ltd. is diverse, which is a positive sign for long-term investors.

Abbott India Ltd. Premium Features:

Our website provides premium features tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis. These tools can help long-term investors make better investment decisions by providing more detailed insights into the company's financial performance and valuation.

Abbott India Limited ROCE

The Return on Capital Employed (ROCE) is a key indicator of a company's profitability and efficiency in utilizing its capital. Abbott India Limited ROCE provides an insight into the company's ability to generate profits from its capital investments. By analyzing this ratio, investors and analysts can assess the company's operational efficiency and profitability. You can find Abbott India Limited's ROCE data in the financials table or the ratio section on this page.

Abbott India Limited EBITDA

EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is an important measure of a company's operating performance. By analyzing Abbott India Limited EBITDA, investors and analysts can evaluate the company's profitability without the impact of non-operating expenses and non-cash items. It provides a clear picture of the company's operational efficiency and cash flow generation. You can find Abbott India Limited's EBITDA data in the financials table or the ratio section on this page.

Abbott India Limited DPS

Dividends per Share (DPS) is a measure of the cash paid to shareholders for each share they own in Abbott India Limited. Analyzing Abbott India Limited DPS provides insights into the company's dividend policy and profitability. It is important for investors who seek steady income from their investments. You can find information on Abbott India Limited's DPS in the financials table or the ratio section on this page.

Abbott India Limited EPS

Earnings per Share (EPS) is a key financial metric that indicates the profitability of Abbott India Limited on a per-share basis. By analyzing Abbott India Limited EPS, investors can assess the company's profitability and compare it with other companies in the industry. EPS is an important measure for both growth investors and value investors. You can find Abbott India Limited's EPS data in the financials table or the ratio section on this page.

Read More
X